Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Zimmermann Carolyne — 4D Molecular Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Zimmermann Carolyne

Zimmermann Carolyne

Chief Business Officer at 4D Molecular Therapeutics, Inc. · on record since Jun 9, 2021

Insider trading activity of Zimmermann Carolyne

Transactions on record: 2; since Jun 9, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 3, 2022

Figures computed from official regulatory filings — methodology.

Companies where Zimmermann Carolyne has traded

4D Molecular Therapeutics, Inc.2 tx · Feb 3, 2022

Track record of Zimmermann Carolyne

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Zimmermann Carolyne

Co-insiders of Zimmermann Carolyne

BIOTECHNOLOGY VALUE FUND II LP4D Molecular Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND L P4D Molecular Therapeutics, Inc.
Biotechnology Value Trading Fund OS LP4D Molecular Therapeutics, Inc.
Bizily Scott4D Molecular Therapeutics, Inc.
Burkoth William T.4D Molecular Therapeutics, Inc.
BVF GP HOLDINGS LLC4D Molecular Therapeutics, Inc.
BVF I GP LLC4D Molecular Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BVF II GP LLC4D Molecular Therapeutics, Inc.

BVF INC/IL4D Molecular Therapeutics, Inc.

BVF PARTNERS L P/IL4D Molecular Therapeutics, Inc.

BVF Partners OS Ltd.4D Molecular Therapeutics, Inc.

Chacko Jacob4D Molecular Therapeutics, Inc.

FISHMAN ROBERT S4D Molecular Therapeutics, Inc.

GRAY SUSANNAH4D Molecular Therapeutics, Inc.

Gupta Ashoo4D Molecular Therapeutics, Inc.

HALVORSEN OLE ANDREAS4D Molecular Therapeutics, Inc.

Humer Kristian4D Molecular Therapeutics, Inc.

Kamal Fariborz4D Molecular Therapeutics, Inc.

Kasahara Noriyuki4D Molecular Therapeutics, Inc.

Kim Robert Young4D Molecular Therapeutics, Inc.

Kirn David4D Molecular Therapeutics, Inc.

Kolchinsky Peter4D Molecular Therapeutics, Inc.

LAMPERT MARK N4D Molecular Therapeutics, Inc.

Mehra Uneek4D Molecular Therapeutics, Inc.

Miller-Rich Nancy4D Molecular Therapeutics, Inc.

MILLIGAN JOHN F4D Molecular Therapeutics, Inc.

Moretti August J4D Molecular Therapeutics, Inc.

Ott David C.4D Molecular Therapeutics, Inc.

RA Capital Biotech Fund LP4D Molecular Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLC4D Molecular Therapeutics, Inc.

SBLENDORIO GLENN4D Molecular Therapeutics, Inc.

SCHAFFER DAVID4D Molecular Therapeutics, Inc.

Shabet Rose Sharon4D Molecular Therapeutics, Inc.

Shah Rajeev M.4D Molecular Therapeutics, Inc.

Simms Christopher Paul4D Molecular Therapeutics, Inc.

THEUER CHARLES4D Molecular Therapeutics, Inc.

Tomasello Shawn4D Molecular Therapeutics, Inc.

VIKING GLOBAL INVESTORS LP4D Molecular Therapeutics, Inc.

Viking Global Opportunities GP LLC4D Molecular Therapeutics, Inc.

Viking Global Opportunities Illiquid Investments Sub-Master LP4D Molecular Therapeutics, Inc.

Viking Global Opportunities Parent GP LLC4D Molecular Therapeutics, Inc.

Viking Global Opportunities Portfolio GP LLC4D Molecular Therapeutics, Inc.

YAO TONY DUNG LING4D Molecular Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
4D Molecular Therapeutics, Inc.	Feb 3, 2022	AwardD	35,000	0.00 USD	$0	SEC
4D Molecular Therapeutics, Inc.	Jun 9, 2021	AwardD	60,000	0.00 USD	$0	SEC